(Q36884501)

16 August 2017

1 reference

title

The immuno-endocrine component in the pathogenesis of tuberculosis (English)

1 reference

16 August 2017

1 reference

Bottasso O

1

1 reference

16 August 2017

Bay ML

series ordinal

2

1 reference

16 August 2017

Besedovsky H

series ordinal

3

1 reference

16 August 2017

del Rey A

series ordinal

4

1 reference

16 August 2017

publication date

1 August 2007

1 reference

Scandinavian Journal of Immunology

16 August 2017

published in

1 reference

16 August 2017

volume

66

1 reference

16 August 2017

issue

2-3

1 reference

16 August 2017

page(s)

166-175

1 reference

Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01962.X

Protective effect of Bacillus Calmette-Guerin (BCG) vaccination in children with extra-pulmonary tuberculosis, but not the pulmonary disease. A case-control study in Rosario, Argentina

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01962.X

Immunology of tuberculosis and implications in vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01962.X

Management of tuberculosis in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01962.X

Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01962.X

Progress in tuberculosis vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01962.X

Control of human host immunity to mycobacteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01962.X

Human immunodeficiencies that predispose to intracellular bacterial infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01962.X

Animal models of cavitation in pulmonary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01962.X

21 January 2018

Immunity to mycobacteria

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01962.X

Aerosol infection of mice with recombinant BCG secreting murine IFN-gamma partially reconstitutes local protective immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01962.X

Treatment of multidrug-resistant pulmonary tuberculosis with interferon-gamma via aerosol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01962.X

Decreased IFN- gamma and increased IL-4 production by human CD8(+) T cells in response to Mycobacterium tuberculosis in tuberculosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01962.X

Defective interleukin 2 production and responsiveness in human pulmonary tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01962.X

In vitro synthesis of interferon-gamma, interleukin-4, transforming growth factor-beta and interleukin-1 beta by peripheral blood mononuclear cells from tuberculosis patients: relationship with the severity of pulmonary involvement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01962.X

Down-modulation of lung immune responses by interleukin-10 and transforming growth factor beta (TGF-beta) and analysis of TGF-beta receptors I and II in active tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01962.X

Functional diversity of helper T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01962.X

Regulation of the interleukin (IL)-12R beta 2 subunit expression in developing T helper 1 (Th1) and Th2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01962.X

Lung remodeling in pulmonary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01962.X

Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01962.X

Immunopathologic effects of tumor necrosis factor alpha in murine mycobacterial infection are dose dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01962.X

Increased release of interleukin-1 beta, interleukin-6, and tumor necrosis factor-alpha by bronchoalveolar cells lavaged from involved sites in pulmonary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01962.X

Active tuberculosis in Africa is associated with reduced Th1 and increased Th2 activity in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01962.X

Detection of in vitro interferon-gamma and serum tumour necrosis factor-alpha in multidrug-resistant tuberculosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01962.X

Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01962.X

Circulating TNF-alpha, TGF-beta, and IL-10 in tuberculosis patients and healthy contacts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01962.X

IL-4 in tuberculosis: implications for vaccine design

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01962.X

Th2 biased immune response in cases with active Mycobacterium tuberculosis infection and tuberculin anergy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01962.X

In vivo IL-10 production reactivates chronic pulmonary tuberculosis in C57BL/6 mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01962.X

T lymphocyte phenotypic profile in lung segments affected by cavitary and non-cavitary tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01962.X

IL-10 down-regulates costimulatory molecules on Mycobacterium tuberculosis-pulsed macrophages and impairs the lytic activity of CD4 and CD8 CTL in tuberculosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01962.X

Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01962.X

Natural regulatory T cells in infectious disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01962.X

Regulatory T cells are expanded in blood and disease sites in patients with tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01962.X

Immune-neuro-endocrine interactions: facts and hypotheses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01962.X

Direct and indirect inhibition of Th1 development by progesterone and glucocorticoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01962.X

Reactivation of tuberculosis is associated with a shift from type 1 to type 2 cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01962.X

Arginine, glutamine, and dehydroepiandrosterone reverse the immunosuppressive effect of prednisone during gut-derived sepsis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01962.X

Cortisol and dehydroepiandrosterone affect the response of peripheral blood mononuclear cells to mycobacterial antigens during tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01962.X

Glucocorticoids and immune function: unknown dimensions and new frontiers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01962.X

The role of TGF beta in the pathogenesis of human tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01962.X

Advances in the immunopathogenesis of pulmonary tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01962.X

Endocrine and cytokine responses in humans with pulmonary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01962.X

Endocrine evaluation of patients with critical illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01962.X

The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01962.X

Long-term anti-tumor necrosis factor antibody therapy in rheumatoid arthritis patients sensitizes the pituitary gland and favors adrenal androgen secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01962.X

The Roles of Prolactin, Growth Hormone, Insulin-Like Growth Factor-I, and Thyroid Hormones in Lymphocyte Development and Function: Insights from Genetic Models of Hormone and Hormone Receptor Deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01962.X

Adrenal function in tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01962.X

DHEA and DHEA-S: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01962.X

The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01962.X

Humoral and cell-mediated immunity in mice with genetic deficiencies of prolactin, growth hormone, insulin-like growth factor-I, and thyroid hormone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01962.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01962.X

Mendelian susceptibility to mycobacterial infection in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01962.X

The effects of androstenediol and dehydroepiandrosterone on the course and cytokine profile of tuberculosis in BALB/c mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01962.X

Enhancement Of Intracellular Growth Of Mycobacterium Tuberculosis In Human Monocytes by Transforming Growth Factor- l

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01962.X

Persistence of DNA from Mycobacterium tuberculosis in superficially normal lung tissue during latent infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01962.X

10.1111/J.1365-3083.2007.01962.X

21 January 2018

Identifiers

DOI

1 reference

release_pwxfbdpr2faodhdfvd67qhgkni

16 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/pwxfbdpr2faodhdfvd67qhgkni

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference